Ajinomoto Co., Inc.

    Ajinomoto Co., Inc.

    OOTC:AJINY
    29.28
    USD
    -0.02
    (-0.07%)
    69.81P/E
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    2026 Y
    TTM
    Revenue per Share
    774.77
    850.22
    977.3
    954.21
    980.44
    1,005.86
    1,003.42
    976.99
    1,058.1
    1,271.29
    691.5
    759.81
    - -
    729.55
    Basic EPS, GAAP
    34.33
    39.27
    60.62
    46.4
    52.88
    26.81
    17.18
    54.18
    69.71
    87.99
    41.86
    34.88
    - -
    39.49
    Free Cash Flow per Basic Share
    46.93
    89.01
    61.95
    68.88
    105.03
    102.39
    97.16
    142.7
    127.68
    105.68
    77.76
    100.73
    - -
    80.53
    Dividend per Share
    10.13
    10.01
    13.59
    15.08
    15.01
    16.66
    16.01
    15.98
    25.11
    29.59
    18.45
    19.43
    - -
    18.68
    Book Value per Share
    473.81
    487.54
    537.82
    581.27
    623.41
    609.46
    596.69
    627.25
    640.87
    684.86
    354.41
    332.79
    - -
    748.25
    Tangible Book Value per Share
    491.22
    514.09
    464.57
    466.65
    481.15
    477.02
    394.84
    455.57
    526.2
    621.97
    310.75
    299.43
    - -
    589.87
    Basic Weighted Avg Shares
    1,228
    1,184
    1,176
    1,144
    1,137
    1,108
    1,096
    1,097
    1,086
    1,069
    2,081
    2,014
    973
    1,030
    Sales/Revenue/Turnover
    951,359
    1,006,630
    1,149,427
    1,091,195
    1,114,784
    1,114,308
    1,100,039
    1,071,453
    1,149,370
    1,359,115
    1,439,231
    1,530,556
    - -
    751,227
    Operating Margin (%)
    6.5
    7.4
    8.57
    7.43
    6.7
    4.86
    4.66
    9.32
    10.75
    10.64
    9.86
    7.03
    - -
    9.4
    Depreciation Expense
    47,335
    45,577
    50,852
    46,273
    51,783
    52,485
    61,986
    63,045
    66,234
    71,820
    78,298
    86,461
    - -
    40,596
    Net Income, GAAP
    42,159
    46,495
    71,292
    53,065
    60,124
    29,698
    18,837
    59,416
    75,725
    94,065
    87,121
    70,272
    - -
    40,664
    Effective Tax Rate (%)
    31.66
    29.95
    20.89
    25.05
    18.97
    32.35
    41.77
    32.59
    34.49
    28.47
    28.17
    25.44
    - -
    29.4
    Profit Margin (%)
    4.43
    4.62
    6.2
    4.86
    5.39
    2.67
    1.71
    5.55
    6.59
    6.92
    6.05
    4.59
    - -
    5.41
    Working Capital
    312,680
    231,696
    374,129
    312,651
    324,049
    299,411
    203,335
    248,830
    256,788
    275,893
    208,063
    316,710
    - -
    -333,881
    LT Debt
    104,428
    74,073
    243,226
    298,964
    309,711
    306,636
    273,685
    291,519
    271,281
    239,244
    254,224
    416,207
    - -
    442,401
    Total Equity
    655,505
    725,331
    680,727
    690,673
    720,613
    685,960
    592,070
    667,846
    739,744
    822,968
    884,448
    813,273
    - -
    833,266
    Return on Invested Capital (%)
    5.17
    5.96
    8.18
    6.1
    5.76
    3.5
    3
    6.76
    7.74
    9.44
    8.28
    6.12
    - -
    3.82
    Return on Capital (%)
    4.75
    4.74
    7.25
    4.34
    5.29
    2.28
    1.25
    5.31
    7.18
    9.23
    6.98
    5.78
    - -
    2.76
    Return on Common Equity (%)
    7.37
    8.02
    11.79
    8.18
    8.75
    4.29
    2.83
    8.85
    10.94
    13.17
    11.85
    9.98
    - -
    5.31

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Mar'24
    Jun'25
    Sep'25
    ST Debt
    188,270
    - -
    48,972
    LT Borrowings
    254,224
    - -
    442,401
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    1,025
    - -
    1,008
    Market Capitalization
    2,939,710
    2,930,556
    2,838,842

    Working Capital

    JPY

    •

    in mil. unless spec.
    Mar'24
    Jun'25
    Sep'25
    Total Current Assets
    - -
    - -
    - -
    Cash, Cash Equivalents & STI
    194,187
    - -
    196,124
    Accounts Receivable, Net
    185,564
    - -
    175,884
    Inventories
    287,122
    - -
    303,879
    Total Current Liabilities
    501,569
    - -
    333,881
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    188,270
    - -
    48,972
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    - -
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    339,521
    348,482
    379,641
    371,586
    1,439,231
    2025
    - -
    - -
    - -
    - -
    1,530,556
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    25.89
    18.5
    29.97
    - -
    41.86
    2025
    - -
    - -
    - -
    - -
    34.88
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    17.78
    0.46
    18.44
    - -
    18.45
    2025
    - -
    - -
    - -
    - -
    19.43
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • defenseworld.net

      Ajinomoto (OTCMKTS:AJINY) & Rocky Mountain Chocolate Factory (NASDAQ:RMCF) Critical Contrast

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJNMY) Q1 2027 Earnings Call Transcript

    • wsj.com

      AI Needs Ajinomoto's Film, But Its CEO Won't Raise Prices Just Because

    • seekingalpha.com

      Ajinomoto Q4 Earnings: The Good And The Bad

    • defenseworld.net

      Analyzing J. M. Smucker (NYSE:SJM) and Ajinomoto (OTCMKTS:AJINY)

    • prnewswire.com

      Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

    • wsj.com

      Is MSG Maker Ajinomoto Sitting on an AI Goldmine? This Investor Thinks So

    • defenseworld.net

      Critical Contrast: Ajinomoto (OTCMKTS:AJINY) vs. J. M. Smucker (NYSE:SJM)

    • businesswire.com

      Palliser Capital Publishes Value Enhancement Plan for Ajinomoto

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJINY) Q3 2026 Earnings Call Transcript

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJINY) Q2 2026 Earnings Call Transcript

    • seekingalpha.com

      Ajinomoto Co., Inc. - Special Call

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJINY) Q1 2026 Earnings Call Transcript

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript

    • globenewswire.com

      L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co.

    • globenewswire.com

      L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik

    • businesswire.com

      PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJINY) Q2 2024 Earnings Call Transcript

    • seekingalpha.com

      Ajinomoto Co., Inc. (AJINY) Q1 2024 Earnings Call Transcript

    • prnewswire.com

      Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium